Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer

ÖZYİĞİT G., HÜRMÜZ P., YÜCE D., Akyol F.

WORLD JOURNAL OF CLINICAL ONCOLOGY, vol.10, no.8, pp.283-292, 2019 (ESCI)

  • Publication Type: Article / Article
  • Volume: 10 Issue: 8
  • Publication Date: 2019
  • Doi Number: 10.5306/wjco.v10.i8.283
  • Journal Name: WORLD JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.283-292
  • Keywords: Prostate cancer, Androgen deprivation therapy, Radiotherapy, Testosterone, Castration, ANDROGEN-DEPRIVATION THERAPY, SERUM TESTOSTERONE, SUPPRESSION, RADIOTHERAPY, TRIAL, LEUPROLIDE, DURATION
  • Hacettepe University Affiliated: Yes

Abstract

BACKGROUND